RADIANT
Showing 1 - 25 of 665
High Caries Risk Patients Trial in Ismailia (KetacTM Universal AplicapTM, KetacTM Universal AplicapTM with light cure)
Completed
- High Caries Risk Patients
- KetacTM Universal AplicapTM
- KetacTM Universal AplicapTM with light cure
-
Ismailia, EgyptFaculty of dentistry, Suez Canal university
Feb 15, 2023
Host Blood RNA Signatures for Diagnosis of TB (RADIANT)
Recruiting
- Tuberculosis
- NanoString nCounter assay
-
Cape Town, Western Cape, South Africa
- +1 more
Sep 12, 2022
End-stage Renal Disease Trial (Intensive Intervention)
Completed
- End-stage Renal Disease
- Intensive Intervention
- (no location specified)
Oct 4, 2021
Vulvovaginal Atrophy Trial in United States (WC3011 Estradiol Vaginal Cream)
Completed
- Vulvovaginal Atrophy
- WC3011 Estradiol Vaginal Cream
-
Huntsville, Alabama
- +63 more
Apr 11, 2022
Migraine, With or Without Aura Trial in United States (Rimegepant)
Completed
- Migraine, With or Without Aura
-
Birmingham, Alabama
- +97 more
Dec 15, 2022
Acute Cerebral Ischemia Trial in India (Sovateltide, Normal Saline)
Recruiting
- Acute Cerebral Ischemia
- Sovateltide
- Normal Saline
-
Guntur, Andhra Pradesh, India
- +5 more
Jul 18, 2023
Adolescent Behavior, Interpersonal Relations, Domestic Violence Trial in Houston (Me & You - Tech)
Not yet recruiting
- Adolescent Behavior
- +3 more
- Me & You - Tech
-
Houston, TexasUniversity of Texas Health Science Center at Houston
Jan 24, 2022
Pain, Stress Disorders, Post-Traumatic Trial in Lexington, Philadelphia (eScreen system)
Recruiting
- Pain
- Stress Disorders, Post-Traumatic
- eScreen system
-
Lexington, Kentucky
- +1 more
Feb 7, 2022
Lateral Canthal Lines, Crow's Feet Trial in United States (Vehicle, botulinum toxin, Type A)
Completed
- Lateral Canthal Lines
- Crow's Feet
- Vehicle
- botulinum toxin, Type A
-
Miami, Florida
- +5 more
Apr 19, 2022
Diabetes, Type 1 Trial in Belgium, France, United Kingdom (Omnipod 5 System)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Omnipod 5 System
-
Leuven, Belgium
- +16 more
Jun 20, 2023
Visual Acuity Trial in Jacksonville (JJVC Investigational Contact Lens, 1-DAY ACUVUE® DEFINE® Radiant Sweet™)
Completed
- Visual Acuity
- JJVC Investigational Contact Lens
- 1-DAY ACUVUE® DEFINE® Radiant Sweet™
-
Jacksonville, FloridaVRC-East
Apr 30, 2021
Binge Eating Disorder Trial in Germany, United States (SPD489 (Lisdexamfetamine dimesylate), Placebo)
Completed
- Binge Eating Disorder
- SPD489 (Lisdexamfetamine dimesylate)
- Placebo
-
Tucson, Arizona
- +47 more
Jun 24, 2021
Essential Hypertension Trial in Worldwide (Aprocitentan 5 mg, Aprocitentan 10 mg, Aprocitentan 25 mg)
Completed
- Essential Hypertension
- Aprocitentan 5 mg
- +5 more
-
Fort Payne, Alabama
- +90 more
Nov 22, 2022
Migraine, With or Without Aura Trial in United States (Rimegepant, Placebo)
Osteoarthritis, Knee Trial in United States (Naproxen Sodium (Aleve, BAY117031), Acetaminophen ER, Celecoxib)
Completed
- Osteoarthritis, Knee
- Naproxen Sodium (Aleve, BAY117031)
- +3 more
-
Chandler, Arizona
- +4 more
Jun 3, 2020
Cerebral Ischemia, Cerebral Infarction, Stroke, Acute Trial in India (Normal Saline along with standard treatment, PMZ-1620
Completed
- Cerebral Ischemia
- +2 more
- Normal Saline along with standard treatment
- PMZ-1620 (sovateltide) along with standard treatment
-
Agra, Uttar Pradesh, India
- +10 more
Feb 11, 2022
Bladder Cancer Trial in Canada (Durvalumab, Immune Modulating Radiation)
Recruiting
- Bladder Cancer
- Durvalumab
- Immune Modulating Radiation
-
Edmonton, Alberta, Canada
- +3 more
Jun 14, 2021
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in United States (Tanezumab 2.5 mg, Tanezumab 5 mg, Tanezumab 10 mg)
Terminated
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Tanezumab 2.5 mg
- +2 more
-
Mobile, Alabama
- +99 more
Apr 16, 2021
Osteoporosis Trial in Worldwide (ALX1-11 (drug))
Completed
- Osteoporosis
- ALX1-11 (drug)
-
Birmingham, Alabama
- +131 more
May 13, 2021